Try our beta test site

Efficacy and Safety of SPD465 in Adults With Moderately Symptomatic ADHD.

This study has been completed.
Sponsor:
Information provided by:
Shire
ClinicalTrials.gov Identifier:
NCT00152022
First received: September 7, 2005
Last updated: January 12, 2017
Last verified: January 2017